NAT10 and urinary bladder carcinoma: This interaction bolstered cisplatin chemoresistance in bladder cancer cells by augmenting DNA damage repair mechanisms, underscoring the pivotal role of NAT10 in mediating therapeutic resistance via modulation of cellular repair pathways [47].